Search research articles
Contact Us
Filters
Showing results (241-250 of 342) with videos related to
Page
of 35
Sort By:
The Oncologist
|
September 27, 2023
The Perceived Usability of Virtual Visits Among Black Adults' Receiving Oncology Care: A Qualitative Analysis
Samantha Tam, Christine Neslund-Dudas, Amy M Barrett, et al.
Kidney Cancer (Clifton, Va.)
|
November 26, 2019
Everolimus Exposure as a Predictor of Toxicity in Renal Cell Cancer Patients in the Adjuvant Setting: Results of a Pharmacokinetic Analysis for SWOG S0931 (EVEREST), a Phase III Study (NCT01120249)
Timothy W Synold, Melissa Plets, Catherine M Tangen, et al.
Urologic Oncology
|
June 7, 2021
Telemedicine in management of genitourinary malignancies: Patient and physician perspectives
Ezra J Margolin, Luis A Pina Martina, Caleb H Miles, et al.
Molecular Cancer Therapeutics
|
June 18, 2011
Rationally designed treatment for solid tumors with MAPK pathway activation: a phase I study of paclitaxel and bortezomib using an adaptive dose-finding approach
Janice M Mehnert, Antoinette R Tan, Rebecca Moss, et al.
Cancer
|
September 26, 2018
Comparative effectiveness of radical prostatectomy with adjuvant radiotherapy versus radiotherapy plus androgen deprivation therapy for men with advanced prostate cancer
Thomas L Jang, Neal Patel, Izak Faiena, et al.
Journal of Clinical Urology
|
March 12, 2019
Effect of alvimopan on gastrointestinal recovery and length of hospital stay after retroperitoneal lymph node dissection for testicular cancer
Kushan D Radadia, Nicholas J Farber, Alexandra L Tabakin, et al.
Cancer Chemotherapy and Pharmacology
|
August 30, 2019
A phase I trial of MK-2206 and hydroxychloroquine in patients with advanced solid tumors
Janice M Mehnert, Amanda D Kaveney, Jyoti Malhotra, et al.
Oncotarget
|
April 10, 2023
A phase I trial of riluzole and sorafenib in patients with advanced solid tumors: CTEP #8850
Kristen R Spencer, Daniella E Portal, Joseph Aisner, et al.
Cancer Chemotherapy and Pharmacology
|
October 20, 2021
A phase I study of veliparib with cyclophosphamide and veliparib combined with doxorubicin and cyclophosphamide in advanced malignancies
Antoinette R Tan, Nancy Chan, Brian F Kiesel, et al.
Cancer Medicine
|
February 9, 2020
Individual and joint effects of metformin and statins on mortality among patients with high-risk prostate cancer
Xiang-Lin Tan, Jian-Yu E, Yong Lin, et al.
Page
of 35
Search research articles
Search
Showing results (241-250 of 342) with videos related to
Sort By:
Page
of 35
The Oncologist
|
September 27, 2023
The Perceived Usability of Virtual Visits Among Black Adults' Receiving Oncology Care: A Qualitative Analysis
Samantha Tam, Christine Neslund-Dudas, Amy M Barrett, et al.
Kidney Cancer (Clifton, Va.)
|
November 26, 2019
Everolimus Exposure as a Predictor of Toxicity in Renal Cell Cancer Patients in the Adjuvant Setting: Results of a Pharmacokinetic Analysis for SWOG S0931 (EVEREST), a Phase III Study (NCT01120249)
Timothy W Synold, Melissa Plets, Catherine M Tangen, et al.
Urologic Oncology
|
June 7, 2021
Telemedicine in management of genitourinary malignancies: Patient and physician perspectives
Ezra J Margolin, Luis A Pina Martina, Caleb H Miles, et al.
Molecular Cancer Therapeutics
|
June 18, 2011
Rationally designed treatment for solid tumors with MAPK pathway activation: a phase I study of paclitaxel and bortezomib using an adaptive dose-finding approach
Janice M Mehnert, Antoinette R Tan, Rebecca Moss, et al.
Cancer
|
September 26, 2018
Comparative effectiveness of radical prostatectomy with adjuvant radiotherapy versus radiotherapy plus androgen deprivation therapy for men with advanced prostate cancer
Thomas L Jang, Neal Patel, Izak Faiena, et al.
Journal of Clinical Urology
|
March 12, 2019
Effect of alvimopan on gastrointestinal recovery and length of hospital stay after retroperitoneal lymph node dissection for testicular cancer
Kushan D Radadia, Nicholas J Farber, Alexandra L Tabakin, et al.
Cancer Chemotherapy and Pharmacology
|
August 30, 2019
A phase I trial of MK-2206 and hydroxychloroquine in patients with advanced solid tumors
Janice M Mehnert, Amanda D Kaveney, Jyoti Malhotra, et al.
Oncotarget
|
April 10, 2023
A phase I trial of riluzole and sorafenib in patients with advanced solid tumors: CTEP #8850
Kristen R Spencer, Daniella E Portal, Joseph Aisner, et al.
Cancer Chemotherapy and Pharmacology
|
October 20, 2021
A phase I study of veliparib with cyclophosphamide and veliparib combined with doxorubicin and cyclophosphamide in advanced malignancies
Antoinette R Tan, Nancy Chan, Brian F Kiesel, et al.
Cancer Medicine
|
February 9, 2020
Individual and joint effects of metformin and statins on mortality among patients with high-risk prostate cancer
Xiang-Lin Tan, Jian-Yu E, Yong Lin, et al.
Page
of 35